CochLear PE Ratio 2023-2024 | CHEOY

Current and historical p/e ratio for CochLear (CHEOY) from 2023 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. CochLear PE ratio as of August 18, 2025 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

CochLear PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-08-19 96.27 0.00
2024-12-31 89.02 0 0.00
2024-06-30 109.21 0 0.00
Sector Industry Market Cap Revenue
Medical Medical Services $12.576B $1.525B
Cochlear Limited provides implantable hearing solutions principally in the Americas, Europe, the Middle East, Africa and the Asia Pacific. The company offers cochlear implants, including Nucleus 7 and Kanso sound processors; Carina middle-ear implants and accessories and Baha bone conduction implants. Cochlear Limited is based in Sydney, Australia.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $149.662B 27.76
CVS Health (CVS) United States $88.998B 11.07
Elevance Health (ELV) United States $69.652B 9.37
Cencora (COR) United States $56.292B 18.74
DiDi Global (DIDIY) China $26.968B 28.65
Labcorp Holdings (LH) United States $22.478B 17.87
Natera (NTRA) United States $22.118B 0.00
BioMerieux (BMXMF) France $17.991B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $15.053B 0.00
ICON (ICLR) Ireland $14.420B 13.87
Medpace Holdings (MEDP) United States $13.005B 34.42
Viatris (VTRS) United States $12.393B 4.41
Solventum (SOLV) United States $12.269B 12.66
Revvity (RVTY) United States $10.411B 18.34
Caris Life Sciences,�Inc (CAI) United States $10.110B 0.00
Sonic Healthcare (SKHHY) Australia $9.247B 0.00
Avantor (AVTR) United States $8.699B 12.76
HealthEquity (HQY) United States $7.742B 33.91
Charles River Laboratories (CRL) United States $7.726B 14.66
Bausch + Lomb (BLCO) Canada $5.119B 34.43
Sotera Health (SHC) United States $4.488B 25.08
BrightSpring Health Services (BTSG) United States $4.090B 31.20
Amplifon S.p.A (AMFPF) Italy $3.937B 21.83
GeneDx Holdings (WGS) United States $3.617B 82.83
Alignment Healthcare (ALHC) United States $3.028B 0.00
Concentras Parent (CON) United States $2.931B 18.59
Surgery Partners (SGRY) United States $2.883B 36.27
Organon (OGN) United States $2.412B 2.63
Progyny (PGNY) United States $2.045B 43.24
Premier (PINC) United States $2.012B 15.27
Ardent Health (ARDT) United States $1.806B 6.97
GoodRx Holdings (GDRX) United States $1.779B 30.12
PACS (PACS) United States $1.739B 0.00
Pediatrix Medical (MD) United States $1.393B 9.30
Teladoc Health (TDOC) United States $1.323B 0.00
Omada Health (OMDA) $1.204B 0.00
Establishment Labs Holdings (ESTA) $1.108B 0.00
Ryman Healthcare (RYHTY) New Zealand $0.965B 0.00
Embecta (EMBC) United States $0.788B 4.62
AMN Healthcare Services Inc (AMN) United States $0.745B 9.21
CareDx (CDNA) United States $0.631B 11.62
Performant Healthcare (PHLT) United States $0.601B 0.00
Nutex Health (NUTX) United States $0.525B 7.95
QDM (QDMI) Hong Kong, SAR China $0.525B 90.00
Agilon Health (AGL) United States $0.510B 0.00
Sonida Senior Living (SNDA) United States $0.477B 0.00
InnovAge Holding (INNV) United States $0.477B 0.00
Auna S.A (AUNA) Luxembourg $0.462B 10.40
SBC Medicals (SBC) United States $0.439B 9.64
COMPASS Pathways (CMPS) United Kingdom $0.409B 0.00
Enhabit (EHAB) United States $0.404B 26.57
So-Young (SY) China $0.367B 0.00
Oncology Institute (TOI) United States $0.361B 0.00
LifeMD (LFMD) United States $0.309B 0.00
Beauty Health (SKIN) United States $0.278B 0.00
Shoulder Innovations (SI) United States $0.218B 0.00
DocGo (DCGO) United States $0.164B 0.00
Ascend Wellness Holdings (AAWH) United States $0.137B 0.00
KindlyMD (NAKA) United States $0.091B 0.00
Sera Prognostics (SERA) United States $0.090B 0.00
Biodesix (BDSX) United States $0.062B 0.00
NeueHealth (NEUE) United States $0.059B 0.00
IceCure Medical (ICCM) Israel $0.052B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.042B 0.00
Basel Medical Group (BMGL) Singapore $0.039B 0.00
ModivCare (MODV) United States $0.035B 0.00
SeaStar Medical Holding (ICU) United States $0.023B 0.00
Intelligent Bio Solutions (INBS) United States $0.013B 0.00
Co-Diagnostics (CODX) United States $0.012B 0.00
OSR Holdings (OSRH) United States $0.012B 0.00
BioNexus Gene Lab (BGLC) $0.010B 0.00
XWELL (XWEL) United States $0.007B 0.00
Pheton Holdings (PTHL) China $0.004B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
INVO Fertility (IVF) United States $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00